Yongsheng Li

42PUBLICATIONS
65CO-AUTHORS
Medical bacteriologyRegenerative medicine (incl. stem cells)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 14, 2026
Alistipes-derived monomethyl branched-chain fatty acid iso-15:0 suppresses hepatocellular carcinoma progression by inhibiting Gβγ/PI3K/AKT signaling.

|Sep 09, 2026
Applications of Mesenchymal Stromal Cells for Treatment of Diseases.

|Aug 23, 2026
Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

|Jul 24, 2026
Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study.

|Jul 10, 2026
MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation.

|May 21, 2026
Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer.

Pageof 7

Frequent Collaborators

4 joint publications

Lei Wu

3 joint publications

Wenfeng Fang

3 joint publications

Hongyun Zhao

3 joint publications

Li Zhang